To investigate whether TL1A could modulate cell proliferation in CLL, purified B cells from CLL patients were incubated with exogenous, recombinant TL1A in the presence of anti-IgM stimulation, and cell proliferation was measured using MTT assay. The gene discussed is TNFSF15; the disease is B-cell chronic lymphocytic leukemia.